As part of the National Sleep Foundation's (NSF) mission to improve health and well-being through sleep education and advocacy, today NSF debuts results from the Understanding Sleep Apnea Survey. This ...

Zepbound is the name of the first drug approved by the FDA for obstructive sleep apnea. According to the Mayo Clinic, obstructive sleep apnea is a common sleep-related breathing disorder that ...

Do you feel tired or have a headache when you wake up in the morning? Something might be going wrong while you sleep that you don't know about: obstructive sleep apnea (pronounced app-nee-uh).

A new study supports a link between obstructive sleep apnea and increased risk for Parkinson’s disease and suggests early use ...

(Ivanhoe Newswire) --- Obstructive sleep apnea, or OSA, affects nearly a billion ... MD from the UC San Diego School of Medicine. It’s already FDA-approved to manage diabetes and obesity.

Among patients with OSA, sleep surgery vs CPAP therapy or no treatment reduces the risk for motor vehicle accidents.

Incidence of Parkinson disease significantly lower with early CPAP treatment, but no reduction seen with late CPAP treatment ...

eXciteOSA® is the first FDA-authorized daytime therapy that treats a root cause of snoring and mild obstructive sleep apnea. Using gentle, non-invasive neuromuscular electrical stimulation (NMES ...

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous ...

Apnimed, Inc., a pharmaceutical company focused on discovering, developing, and commercializing first-in-class oral therapies for the neuromuscular dysfunction associated with obstructive sleep apnea ...

Early use of continuous positive airway pressure (CPAP) therapy for sleep apnea could help lower Parkinson's risk, a large ...